Material Insights · Understanding the Material World

CAR-T cell therapy: Science

Principles

The science it rests on, with why each principle matters to it

Relies on
  • Acquired immunity and antibodies Killer T cells normally destroy a cell only when they recognise both a foreign marker and the body's own molecules, as Doherty and Zinkernagel found [6]; a CAR gives them antibody-type targeting instead [2].
  • The genetic code The T cells are given a new gene, and their own machinery reads it to build the receptor [3].

as of 2026-11-11

Discoveries

The discoveries that made it possible: when, by whom and what was found

YearWhoWhat
1973Peter Doherty and Rolf ZinkernagelKiller T cells must recognise both a virus and the body's own molecules to kill an infected cell (work of 1973 to 1975) [6]
1975Georges Köhler and César MilsteinThe hybridoma technique for making monoclonal antibodies [7]
1989Gideon Gross, Tova Waks and Zelig EshharChimeric receptors that give T cells antibody-type targeting [2]

as of 2026-11-11

The science explained

The science behind it explained for a curious reader

T cells are the immune system's security guards. Each carries receptors that check other cells for signs of trouble, but they only react when the trouble is shown to them in a particular way, alongside the body's own molecules [6]. Many cancer cells slip past. Antibodies work differently: they can grab a chosen marker on any cell directly, and since 1975 scientists have been able to make antibodies to order [7]. A chimeric antigen receptor brings antibody-type targeting to a T cell [2]. A T cell carrying it can recognise a marker such as CD19 on a leukaemia cell, switch on, kill the cell and then copy itself, so the dose keeps working inside the body [4].

as of 2026-11-11

Sources

  1. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity Proceedings of the National Academy of Sciences (Gross, Waks, Eshhar), record at MIGAL, 1989
  2. FDA Approves Novartis' CAR-T Drug, First Gene Therapy Approval in US Pharmaceutical Technology, 2017
  3. FDA Approves Personalized Cellular Therapy for Advanced Leukemia (news release) Penn Medicine, 2017
  4. The Nobel Prize in Physiology or Medicine 1996 - Press release Nobel Assembly at Karolinska Institutet, 1996
  5. The Nobel Prize in Physiology or Medicine 1984: press release Nobel Assembly at Karolinska Institutet (nobelprize.org)